Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evoke Pharma Inc EVOK

Healthcare
Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development and commercialization of drugs to treat gastrointestinal (GI) disorders and diseases. The Company operates through the development and commercialization of pharmaceutical products. It is developing its product, Gimoti (metoclopramide) nasal spray, the first and only nasally administered... see more

Recent & Breaking News (NDAQ:EVOK)

Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent

GlobeNewswire November 27, 2023

United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI

GlobeNewswire November 14, 2023

Evoke Pharma Reports Third Quarter 2023 Financial Results

GlobeNewswire November 9, 2023

Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023

GlobeNewswire October 31, 2023

Evoke Pharma's Abstract Entitled "Superiority of Nasal Spray Compared to Orally Administered Metoclopramide in Reducing Healthcare Costs in Treating Diabetic Gastroparesis Patients" to Be Presented at The American College of Gastroenterology (ACG) 2023 Annual Meeting

GlobeNewswire October 18, 2023

Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI®

GlobeNewswire September 14, 2023

Evoke Pharma Reports Second Quarter 2023 Financial Results

GlobeNewswire August 10, 2023

Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) Meeting

GlobeNewswire August 7, 2023

Evoke Pharma and EVERSANA Announce Abstract Selection for Plenary Oral Presentation at The American College of Gastroenterology (ACG) 2023 Annual Meeting

GlobeNewswire July 25, 2023

Evoke Pharma to Host First Key Opinion Leader Webinar on Healthcare Resource Utilization Data Related to Gastroparesis and its Treatment

GlobeNewswire June 14, 2023

Evoke Pharma Reports First Quarter 2023 Financial Results

GlobeNewswire May 15, 2023

Real-World Data Presented by Evoke Pharma and EVERSANA at Digestive Disease Week 2023 Shows Gimoti® Meaningfully Reduces Utilization of Healthcare Resources

GlobeNewswire May 9, 2023

Evoke Pharma's Real-World Healthcare Utilization Data Comparing GIMOTI® to Oral Metoclopramide to Be Presented at Digestive Disease Week (DDW) 2023

GlobeNewswire May 4, 2023

New GIMOTI Patent Listed in FDA Orange Book

GlobeNewswire May 1, 2023

United States Patent and Trademark Office (USPTO) Grants Evoke Pharma a Formulation Patent Covering GIMOTI

GlobeNewswire April 20, 2023

Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI-Related Patent

GlobeNewswire April 6, 2023

Evoke Pharma & EVERSANA Announce Compelling Real-World Data on the Impact of GIMOTI in Reducing the Utilization of Healthcare Resources to be Presented at the Academy of Managed Care Pharmacy (AMCP) 2023

GlobeNewswire March 23, 2023

Evoke Pharma Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 21, 2023

Evoke Pharma to Report Fourth Quarter and Full Year 2022 Results on March 21, 2023

GlobeNewswire March 15, 2023

Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Study Comparing GIMOTI® and Oral Metoclopramide at the Digestive Disease Week Plenary Session

GlobeNewswire February 21, 2023